Tag: opioid treatment

Survey Published for Opioid Use Disorder Contacts

Member News, Patient Safety and Quality

In preparation for the state’s anticipated grant program to implement an Emergency Department Medication for Opioid Use Disorder (ED MOUD) program, the MHA is asking all members to fill out a short survey by Sept. 23 to provide contact information for those within each member organization who support OUD work.

The Michigan Senate and House recently both passed Senate Bill 597, which requires all Michigan emergency departments who do not otherwise opt-out to implement an ED MOUD program. The governor has not yet signed the bill into law, but the MHA anticipates Gov. Whitmer will sign the bill in the coming months.

While ED MOUD programming currently exists and many Michigan hospitals are already implementing it, the bill will require the Michigan Department of Health and Human Services to create a grant program to provide financial support to emergency departments to implement ED MOUD programs. This funding will be available only to those with more than 50 overdose encounters a year. Hospitals will be required to either opt-out or complete an application for funding. As such, the MHA Keystone Center – which has been working closely with Michigan hospitals currently implementing the ED MOUD program – is preparing to support members once the bill is signed. Given the anticipated tight turnaround to complete paperwork, it is imperative for the MHA Keystone Center to have the appropriate contacts to aid in the registration or opt-out process.

Members with questions about the requirements can reach out to the MHA Keystone Center.

 

Application Closing Soon for ED Medication for Opioid Use Disorder Initiative

Patient Safety and Quality

In partnership with the MHA Keystone Center, the Michigan Opioid Partnership and the Michigan Department of Health and Human Services, the Community Foundation for Southeast Michigan (CFSEM) has launched an Emergency Department (ED) Medication for Opioid Use Disorder Initiative and funding opportunity for Michigan hospitals. The initiative aims to increase access to evidence-based medication for opioid use disorder and support the transition to long-term, office-based treatment upon discharge. More information about the initiative is available in an online video.

The application opened Jan. 3 and will close Jan. 21. Applications submitted after Jan. 21 may be accepted on a rolling basis if grant funds remain. Grant funds are limited and are available on a first-come, first-served basis.

Eligibility will be determined by the number of encounters each hospital has annually to treat patients for opioid-related overdoses. Eligible hospitals are encouraged to coordinate and apply as a system. If two or more eligible hospitals from the same system are interested in applying, they are encouraged to contact the CFSEM to discuss the possibility of applying as a system. Eligibility for grant funding is outlined as follows:

  • Hospitals with more than 100 encounters annually are eligible for technical assistance and up to $150,000.
  • Hospitals with 50-100 encounters annually are eligible for technical assistance and up to $75,000.
  • Hospitals with fewer than 50 encounters annually are eligible for technical assistance and are strongly encouraged to contact the CFSEM if interested. Currently, hospitals with fewer than 50 encounters annually are ineligible for funding.

For the most current information, application instructions and grant guidelines, visit the CFSEM website. Members may contact the MHA Keystone Center with questions and email CFSEM to learn more or to request a meeting to discuss this opportunity.